These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 247708)

  • 21. [Reports of secondary effects].
    Ugeskr Laeger; 1974 Aug; 136(32):1822. PubMed ID: 4410753
    [No Abstract]   [Full Text] [Related]  

  • 22. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The P&T Committee's role in managing drugs for rare diseases.
    Tadlock C
    Manag Care Interface; 2007 Jun; 20(6):10, 13. PubMed ID: 17708076
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluating effectiveness of pharmaceuticals.
    Jankel CA
    Am J Hosp Pharm; 1990 Jul; 47(7):1633-5. PubMed ID: 2114794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug committee--an example of a quality circle].
    Hammershøy E; Christensen U; Christensen I
    Ugeskr Laeger; 1991 Aug; 153(34):2330-3. PubMed ID: 1897040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The right drug to the right patient in a right dosage is the goal of clinical pharmacology].
    Lindell B
    Lakartidningen; 1984 May; 81(19):1931-43. PubMed ID: 6727471
    [No Abstract]   [Full Text] [Related]  

  • 27. [What should embrace a national therapeutic drug strategy?].
    Furängen A; Cronlund A
    Lakartidningen; 2010 Jun 2-8; 107(22):1486-7; discussion 1487. PubMed ID: 20645603
    [No Abstract]   [Full Text] [Related]  

  • 28. [Definition of the drug given in 1969 by a committee of WHO experts].
    Quevauviller A; Mabileau J; Vaille C
    Ann Pharm Fr; 1969 Jun; 27(6):403-9. PubMed ID: 5392371
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of drug and therapeutics committee towards drug safety--experiences from western Nepal.
    Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):79-80. PubMed ID: 16401950
    [No Abstract]   [Full Text] [Related]  

  • 30. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].
    Alfaro-Lara ER; Galván-Banqueri M; Prado-Mel E; Santos-Ramos B; Varela-Aguilar JM; Torelló-Iserte J; Castellano Zurera MM; Bautista Paloma FJ
    Farm Hosp; 2010; 34(2):76-84. PubMed ID: 20304366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoting rational drug use through the ASHP Commission on Therapeutics.
    Witmer DR
    Am J Hosp Pharm; 1994 Jun; 51(12):1536. PubMed ID: 8092154
    [No Abstract]   [Full Text] [Related]  

  • 33. [Practical cooperation concerning drug therapy in a local area. The drug committee in the primary sector in Holstebro].
    Gade-Kristensen H; Knudsen E; Larsen NA; Osterbye P
    Ugeskr Laeger; 1986 Oct; 148(42):2699-703. PubMed ID: 3787780
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: Regulating the introduction of new drugs.
    Lancet; 1974 Mar; 1(7856):490. PubMed ID: 4131888
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The other side of the fence: hospital P&T committee members' role in drug selection.
    Archambault GF
    Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029
    [No Abstract]   [Full Text] [Related]  

  • 37. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of drug product selection in health care and the role of the pharmacy and therapeutics committee.
    Cohen P
    Manag Care Interface; 2006 Dec; 19(12):15-6. PubMed ID: 17274477
    [No Abstract]   [Full Text] [Related]  

  • 39. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [International drug monitoring].
    Nir I
    Harefuah; 1973 Jan; 84(1):41-2. PubMed ID: 4692808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.